Sowell Financial Services’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-83
Closed -$7K 2890
2021
Q1
$7K Hold
83
﹤0.01% 2489
2020
Q4
$7K Hold
83
﹤0.01% 2183
2020
Q3
$7K Hold
83
﹤0.01% 1921
2020
Q2
$8K Hold
83
﹤0.01% 1785
2020
Q1
$2K Hold
83
﹤0.01% 2144
2019
Q4
$3K Hold
83
﹤0.01% 2118
2019
Q3
$1K Buy
+83
New +$1.74K ﹤0.01% 2336

Other funds holding VBIV

Sowell Financial Services's VBIV Position: Q2 2021 in Review

Sowell Financial Services sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2021, closing a stake of 83 shares — an estimated $7K sold.

Sowell Financial Services first reported a position in VBIV in Q3 2019 and held it in 7 quarters. The position peaked at $8K in Q2 2020. 134 funds tracked by Wall St. Rank hold VBIV as of Q2 2021.

  • Sowell Financial Services reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 83 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2021, an estimated $7K.
  • Sowell Financial Services first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $8K in Q2 2020.
  • 134 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.